Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) shares were up 1.5% on Wednesday . The stock traded as high as $0.6796 and last traded at $0.6698. 86,810 shares traded hands during trading, an increase of 26% from the average session volume of 68,817 shares. The stock had previously closed at $0.66.
Retractable Technologies Stock Performance
The stock has a market capitalization of $20.06 million, a PE ratio of -1.24 and a beta of 1.27. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The business’s fifty day moving average price is $0.68 and its 200-day moving average price is $0.71.
Hedge Funds Weigh In On Retractable Technologies
A number of hedge funds and other institutional investors have recently bought and sold shares of RVP. Susquehanna International Group LLP raised its position in shares of Retractable Technologies by 135.3% during the 3rd quarter. Susquehanna International Group LLP now owns 54,546 shares of the company’s stock valued at $46,000 after buying an additional 31,362 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Retractable Technologies by 4.5% during the 4th quarter. Renaissance Technologies LLC now owns 447,007 shares of the company’s stock worth $345,000 after acquiring an additional 19,443 shares during the last quarter. Finally, Eversept Partners LP grew its position in Retractable Technologies by 59.9% in the fourth quarter. Eversept Partners LP now owns 580,919 shares of the company’s stock worth $449,000 after acquiring an additional 217,604 shares in the last quarter. Hedge funds and other institutional investors own 7.58% of the company’s stock.
Retractable Technologies Company Profile
Retractable Technologies, Inc is a U.S.-based medical device company specializing in the design, development and manufacture of safety-engineered injection technologies aimed at reducing needlestick injuries. Headquartered in Little Elm, Texas, Retractable Technologies offers proprietary needle retraction systems that automatically withdraw the needle into the syringe barrel immediately after use, thereby enhancing safety for healthcare workers and patients.
The company’s flagship product, VanishPoint®, features a one-handed, automatic retraction mechanism and is available in multiple configurations, including standard syringes and Luer-lock fittings.
Read More
- Five stocks we like better than Retractable Technologies
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
- Why Palantir’s Google Cloud Deal Could Change the Debate
- AI’s Power Problem Is Turning Nuclear Stocks Into a Bigger Market Story
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
